Guido Oelkers

Guido Oelkers

Chief Executive Officer at SWEDISH ORPHAN BIOVITRUM AB

Net worth: 33 M $ as of 31/05/2026

61 year
Health Technology
Consumer Services
Finance

Profile

Guido Oelkers is a businessperson who has been at the helm of 8 different companies. Dr. Oelkers is President & Chief Executive Officer for Swedish Orphan Biovitrum AB, Chief Executive Officer of BSN medical BV and Chief Executive Officer & Director at BSN medical International Holding GmbH & Co. KG. He is also on the board of Dova Pharmaceuticals, Inc. and Swedish Orphan Biovitrum, Inc. In the past Guido Oelkers occupied the position of Group Chief Executive Officer of BSN medical GmbH, Chief Executive Officer at BSN Medical Holding, President & Chief Executive Officer at Gambro AB, President & Chief Executive Officer for Gambro Lundia AB, Chief Executive Officer of Invida Group Pte Ltd., Executive Vice President-Commercial Operations at Takeda A, Principal at Aventis Pharma Deutschland GmbH and Executive Vice President-Commercial Operations at Takeda Pharmaceuticals International GmbH. Dr. Oelkers received a doctorate from the University of South Australia and a graduate degree from London South Bank University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
12/06/2026 685,881 ( 0.19% ) 33 M $ 31/05/2026

Guido Oelkers active positions

CompaniesPositionStart
SWEDISH ORPHAN BIOVITRUM AB Chief Executive Officer 22/05/2017
DOVA PHARMACEUTICALS, INC. Director/Board Member 12/11/2019
Chairman -
Director/Board Member -
Chief Executive Officer -
Chief Executive Officer -

Former positions of Guido Oelkers

CompaniesPositionEnd
Chief Executive Officer 01/01/2017
Chief Executive Officer 19/10/2016
Chief Executive Officer 01/01/2013
░░░░░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░ ░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
See the detail of Guido Oelkers's experience

Training of Guido Oelkers

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

43

1st degree connections

20

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies20

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology